Results of studies in medulloblastoma and glioblastoma models demonstrated the suppression of platelet-derived growth factor receptor (PDGFR) and NF-κB pathways, respectively, further supporting garcinol as a pluripotent anti-cancer agent [13,45,46,47]. This evidence concerns the gene PDGFRB and glioblastoma.